BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9171843)

  • 21. Onchocerca-Simulium complexes in Venezuela: can human onchocerciasis spread outside its present endemic areas?
    Basáñez MG; Yarzábal L; Frontado HL; Villamizar NJ
    Parasitology; 2000 Feb; 120 ( Pt 2)():143-60. PubMed ID: 10726276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful control of onchocerciasis vectors in San Vicente Pacaya, Guatemala, 1984-1989.
    Ochoa JO; Castro JC; Barrios VM; Juarez EL; Tada I
    Ann Trop Med Parasitol; 1997 Jul; 91(5):471-9. PubMed ID: 9329983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interruption of Onchocerca volvulus transmission in Northern Venezuela.
    Convit J; Schuler H; Borges R; Olivero V; Domínguez-Vázquez A; Frontado H; Grillet ME
    Parasit Vectors; 2013 Oct; 6(1):289. PubMed ID: 24499653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular approaches to the control of onchocerciasis in Mexico].
    Rodríguez-Pérez MA
    Rev Latinoam Microbiol; 2005; 47(3-4):112-29. PubMed ID: 17061536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin.
    Komlan K; Vossberg PS; Gantin RG; Solim T; Korbmacher F; Banla M; Padjoudoum K; Karabou P; Köhler C; Soboslay PT
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006312. PubMed ID: 29494606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parasitological indicators of onchocerciasis relevant to ivermectin control programmes in the Amazonian focus of Southern Venezuela.
    Vivas-Martínez S; Basáñez MG; Botto C; Villegas L; García M; Curtis CF
    Parasitology; 2000 Nov; 121 Pt 5():527-34. PubMed ID: 11128804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of onchocerciasis with severe skin and eye lesions in a hyperendemic zone in the forest of southwestern Cameroon: clinical, parasitologic, and entomologic findings.
    Somo RM; Enyong PA; Fobi G; Dinga JS; Lafleur C; Agnamey P; Ngosso A; Ngolle EM
    Am J Trop Med Hyg; 1993 Jan; 48(1):14-9. PubMed ID: 8427383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of repeated treatments with ivermectin on the incidence of onchocerciasis in northern Cameroon.
    Boussinesq M; Chippaux JP; Ernould JC; Quillevere D; Prod'hon J
    Am J Trop Med Hyg; 1995 Jul; 53(1):63-7. PubMed ID: 7625535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment and monitoring of onchocerciasis in Latin America.
    Rodríguez-Pérez MA; Unnasch TR; Real-Najarro O
    Adv Parasitol; 2011; 77():175-226. PubMed ID: 22137585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transmission intensity and the patterns of Onchocerca volvulus infection in human communities.
    Basáñez MG; Collins RC; Porter CH; Little MP; Brandling-Bennett D
    Am J Trop Med Hyg; 2002 Dec; 67(6):669-79. PubMed ID: 12518860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transmission of Onchocerca volvulus and prospects for the elimination of its vector, the blackfly Simulium neavei in the Mpamba-Nkusi focus in Western Uganda.
    Lakwo TL; Ndyomugyenyi R; Onapa AW; Twebaze C
    Med Vet Entomol; 2006 Mar; 20(1):93-101. PubMed ID: 16608493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study.
    Osei-Atweneboana MY; Eng JK; Boakye DA; Gyapong JO; Prichard RK
    Lancet; 2007 Jun; 369(9578):2021-2029. PubMed ID: 17574093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vector competence of Simulium oyapockense s.l. and S. incrustatum for Onchocerca volvulus: Implications for ivermectin-based control in the Amazonian focus of human onchocerciasis, a multi-vector-host system.
    Grillet ME; Villamizar NJ; Frontado HL; Cortez J; Escalona M; Botto C; Basáñez MG
    Acta Trop; 2008 Aug; 107(2):80-9. PubMed ID: 18538741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microepidemiology of onchocerciasis in Guatemala: dispersal and survival of Simulium ochraceum.
    Collins RC; Ochoa JO; Cupp EW; Gonzales-Peralta C; Porter CH
    Am J Trop Med Hyg; 1992 Aug; 47(2):147-55. PubMed ID: 1503184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Community-directed vector control to supplement mass drug distribution for onchocerciasis elimination in the Madi mid-North focus of Northern Uganda.
    Jacob BG; Loum D; Lakwo TL; Katholi CR; Habomugisha P; Byamukama E; Tukahebwa E; Cupp EW; Unnasch TR
    PLoS Negl Trop Dis; 2018 Aug; 12(8):e0006702. PubMed ID: 30148838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Onchocerciasis transmission in Ghana: persistence under different control strategies and the role of the simuliid vectors.
    Lamberton PH; Cheke RA; Winskill P; Tirados I; Walker M; Osei-Atweneboana MY; Biritwum NK; Tetteh-Kumah A; Boakye DA; Wilson MD; Post RJ; Basañez MG
    PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003688. PubMed ID: 25897492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative aspects of the infection of Simulium ochraceum by Onchocerca volvulus: the relation of skin microfilarial density to vector infection.
    Campbell CC; Collins RC; Huong AY; Marroquin HF
    Tropenmed Parasitol; 1980 Dec; 31(4):475-8. PubMed ID: 7233543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elimination of Onchocercia volvulus transmission in the Santa Rosa focus of Guatemala.
    Lindblade KA; Arana B; Zea-Flores G; Rizzo N; Porter CH; Dominguez A; Cruz-Ortiz N; Unnasch TR; Punkosdy GA; Richards J; Sauerbrey M; Castro J; Catú E; Oliva O; Richards FO
    Am J Trop Med Hyg; 2007 Aug; 77(2):334-41. PubMed ID: 17690408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal.
    Diawara L; Traoré MO; Badji A; Bissan Y; Doumbia K; Goita SF; Konaté L; Mounkoro K; Sarr MD; Seck AF; Toé L; Tourée S; Remme JH
    PLoS Negl Trop Dis; 2009 Jul; 3(7):e497. PubMed ID: 19621091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Individual host factors associated with Onchocerca volvulus microfilarial densities 15, 80 and 180 days after a first dose of ivermectin.
    Pion SD; Grout L; Kamgno J; Nana-Djeunga H; Boussinesq M
    Acta Trop; 2011 Sep; 120 Suppl 1():S91-9. PubMed ID: 20497765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.